← Leaderboards
Sebastian Joyce
Vanderbilt University
$13,492,547
Attributed
$14,427,595
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,427,595 · 10
VA$0 · 3
By mechanism
R01$13,751,382 · 6
R25$362,236 · 1
R21$302,000 · 1
M01$11,977 · 2
I01$0 · 2
IK6$0 · 1
Top collaborators
- Young J. Kim3 shared
- Michael Korrer1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAntigensT-LymphocyteVaccine DesignResponseVaccinesInsightBaseInfectionEpitopesAdjuvantPathogenCommunicable DiseasesPeptidesImmunityImmuneNanoparticleLungCell PhysiologyDesignClinical PracticeIn VivoMolecularMouse Model
Grant awards (63)
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant$0
I01 · FY2024 · VA · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant$0
I01 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Molecular Basis of CD1D and Natural Killer T Cell Function$510,527
R01 · FY2022 · AI · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$447,565
R01 · FY2022 · DE · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2022 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Molecular Basis of CD1D and Natural Killer T Cell Function$516,236
R01 · FY2021 · AI · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$455,401
R01 · FY2021 · DE
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
Molecular Basis of CD1D and Natural Killer T Cell Function$521,826
R01 · FY2020 · AI · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$461,830
R01 · FY2020 · DE
Short Term Training for Minority Students$90,154
R25 · FY2020 · HL · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2020 · VA · contact PI
Molecular Basis of CD1D and Natural Killer T Cell Function$562,298
R01 · FY2019 · AI · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$467,480
R01 · FY2019 · DE
Short Term Training for Minority Students$90,154
R25 · FY2019 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2019 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$485,385
R01 · FY2018 · DE
Short Term Training for Minority Students$91,774
R25 · FY2018 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2018 · VA · contact PI
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD$395,000
R01 · FY2017 · HL · contact PI
Short Term Training for Minority Students$90,154
R25 · FY2017 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2017 · VA · contact PI
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD$395,000
R01 · FY2016 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2016 · VA · contact PI
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD$386,612
R01 · FY2015 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2015 · VA · contact PI
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD$392,083
R01 · FY2014 · HL · contact PI
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant$0
I01 · FY2014 · VA · contact PI
Molecular Basis of CD1D1 and Natural T Cell Function$362,934
R01 · FY2013 · AI · contact PI
Molecular Basis of CD1D1 and Natural T Cell Function$386,100
R01 · FY2012 · AI · contact PI
Molecular Basis of CD1D1 and Natural T Cell Function$385,275
R01 · FY2011 · AI · contact PI
Molecular Basis of CD1D1 and Natural T Cell Function$387,500
R01 · FY2010 · AI · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$361,887
R01 · FY2010 · AI · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$242,680
R01 · FY2010 · AI · contact PI
Molecular Immunology of Minor Histocompatibility Antigen$372,621
R01 · FY2009 · HL · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$365,542
R01 · FY2009 · AI · contact PI
Molecular Immunology of Minor Histocompatibility Antigen$372,621
R01 · FY2008 · HL · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$365,542
R01 · FY2008 · AI · contact PI
(INF 0106)LARGE-SCALE VACCINIA VIRUS-DERIVED CTL EPITOPE DISCOVERY$539
M01 · FY2008 · RR · contact PI
Molecular Immunology of Minor Histocompatibility Antigen$372,015
R01 · FY2007 · HL · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$371,913
R01 · FY2007 · AI · contact PI
(INF 0106)LARGE-SCALE VACCINIA VIRUS-DERIVED CTL EPITOPE DISCOVERY$11,438
M01 · FY2007 · RR · contact PI
Molecular Immunology of Minor Histocompatibility Antigen$381,250
R01 · FY2006 · HL · contact PI
Molecular Basis of iNKT Cell Ontogeny and Function$381,042
R01 · FY2006 · AI · contact PI
Molecular Basis of CD1d1 and Natural T Cell Function$294,903
R01 · FY2006 · AI · contact PI
Molecular Basis of CD1d1 and Natural T Cell Function$302,000
R01 · FY2005 · AI
Molecular Basis of CD1d1 and Natural T Cell Function$302,000
R01 · FY2004 · AI
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGEN$274,103
R01 · FY2003 · HL
Molecular Basis of CD1d1 and Natural T Cell Function$151,000
R01 · FY2003 · AI
Molecular Basis of CD1d1 and Natural T Cell Function$302,000
R21 · FY2002 · AI
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGEN$266,635
R01 · FY2002 · HL
MOLECULAR BASIS OF CDLDL AND NATURAL T CELL FUNCTION$275,509
R01 · FY2001 · AI
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGEN$259,227
R01 · FY2001 · HL
MOLECULAR BASIS OF CDLDL AND NATURAL T CELL FUNCTION$267,678
R01 · FY2000 · AI
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGEN$252,162
R01 · FY2000 · HL